Cardinal Health, Inc. (CAH) Earnings Call Transcripts

Cardinal Health, Inc.'s Latest Earnings Call - Q4 FY2026

In the fourth quarter of fiscal year 2026, Cardinal Health, Inc. reported total revenue of $63.7 billion, a 6% increase year-over-year, and diluted earnings per share (EPS) of $2.91, reflecting a 40% increase. The company achieved strong performance driven primarily by its Pharmaceutical and Specialty Solutions segment, which saw robust demand. Management provided guidance for fiscal year 2027, projecting EPS growth of 13% to 15%, with a baseline EPS of $12.40 to $12.60, indicating confidence in sustained operational momentum despite potential headwinds from regulatory changes.

Reported metrics

Guidance from management

Management reaffirmed long-term EPS growth guidance of 12% to 14% per year and projected fiscal year 2027 EPS growth of 13% to 15%, with an EPS range of $12.40 to $12.60.

What management said

One thing I would add to that, just to emphasize is that the investments we're making are consistent with a plan, which has been in place for some time. And so we are executing on a multiyear investment plan, all in service of growth, an efficient growth that is also taking advantage of the increasing economies of scale that we are seeing. And so we are sticking to our knitting and getting it done.

The only thing I would add is we did call out the GLP WAC changes at around 500 basis points each, kind of offsetting. So you're trying to figure out the other pieces Well, I think it's probably obvious, I'll say it anyways. It's enough to call out but not so much that we're going to break out that number, so you can certainly think about well below the 500 basis points.

What analysts pressed on

Analysts expressed concerns regarding the impact of regulatory changes, particularly the IRA price changes and the 340B program, on future customer volumes. There were also questions about the sustainability of the strong demand observed in the Pharmaceutical segment and the implications of tariff changes on profitability.

Main topics on the call

• Strong Demand in Pharmaceutical Segment — The Pharmaceutical segment revenue grew 6% to $58.8 billion, driven by strong brand sales and specialty growth. Management noted, "We observed robust brand sales originating from our existing customer base," highlighting...
• Nonrecurring Tariff Refund Impact — Management recorded a one-time $100 million benefit from IEEPA tariff refunds, which contributed significantly to quarterly earnings. They cautioned that this refund is nonrecurring, stating, "We view the refund as nonre...
• Guidance for Fiscal Year 2027 — Cardinal Health expects EPS growth of 13% to 15% for fiscal year 2027, with projected EPS between $12.40 and $12.60. Management reaffirmed long-term EPS growth guidance of 12% to 14% per year, indicating confidence in fu...
• Operational Efficiency and Investments — The company reported $5 billion in adjusted free cash flow for the year, emphasizing continued investments in automation and technology. Management stated, "We continue to make potential investments in automation, techno...

Read the full Cardinal Health, Inc. transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 69 Cardinal Health, Inc. earnings call transcripts on record, spanning January 13, 2020 to August 11, 2026. Based on this history, Cardinal Health, Inc. reports quarterly. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

CAH

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

69

First call

January 13, 2020

Most recent

August 11, 2026

Reporting cadence

quarterly